12:00 AM
 | 
Oct 25, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Gene activation technology regulatory update

TKTX received U.S. Patent No. 5,968,502 covering ex vivo gene therapy using cells modified by TKTX's...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >